News

The global injection pen market is set to witness a growth rate of 7% in the next 5 years. Rising prevalence of chronic ...
Fact checked by Jennifer Klump Although respiratory syncytial virus (RSV) is often associated with children, adults can also ...
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a Phase 3 clinical study titled ‘MagnetisMM-32’ ...
Revenue (GAAP) missed expectations, falling to $156.8 million in Q2 2025—down approximately 14% from the prior year quarter and 5.4% below analyst estimates. GAAP net loss deepened to $0.19 per share, ...
New research is calling for further study on a possible link between COVID-19 jabs and long-term vision issues.
Janus kinase inhibitors can be paired with corticosteroids or used as monotherapy in the treatment of alopecia areata.
FDA approves Novo Nordisk's Alhemo for hemophilia A and B without inhibitors, following strong Phase 3 results showing reduced bleeding episodes.
This article explains how aluminum adjuvants work in vaccines, their proven safety record, and addresses common myths and ...
HOUSTON, TX / ACCESS Newswire / August 4, 2025 / EON Resources Inc. (NYSE American:EONR) (“EON” or the “Company”) is an ...
As patent cliffs approach and new mechanisms gain ground, COPD drugs like HRS-9821 are fast becoming coveted assets.
The interstitial cystitis market is limited by a few approved treatments and high unmet need. However, pipeline innovation ...
What's needed is a course correction. Congress and the Trump administration can start by passing the EPIC Act. They should ...